These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 29843223)
41. Identification of a 4-lncRNA signature predicting prognosis of patients with non-small cell lung cancer: a multicenter study in China. Wang RQ; Long XR; Ge CL; Zhang MY; Huang L; Zhou NN; Hu Y; Li RL; Li Z; Chen DN; Zhang LJ; Wen ZS; Mai SJ; Wang HY J Transl Med; 2020 Aug; 18(1):320. PubMed ID: 32819367 [TBL] [Abstract][Full Text] [Related]
42. TAZ is an independent prognostic factor in non-small cell lung carcinoma: Elucidation at protein level. Malik SA; Khan MS; Dar M; Hussain MU; Mudassar S Cancer Biomark; 2017; 18(4):389-395. PubMed ID: 28128737 [TBL] [Abstract][Full Text] [Related]
43. Reduced expression of liver kinase B1 and Beclin1 is associated with the poor survival of patients with non-small cell lung cancer. Jiang L; Liang X; Liu M; Wang W; Ma J; Guo Q; Han L; Yang C; Nan K Oncol Rep; 2014 Nov; 32(5):1931-8. PubMed ID: 25175672 [TBL] [Abstract][Full Text] [Related]
44. Upregulation of long noncoding RNA PVT1 predicts unfavorable prognosis in patients with clear cell renal cell carcinoma. Bao X; Duan J; Yan Y; Ma X; Zhang Y; Wang H; Ni D; Wu S; Peng C; Fan Y; Gao Y; Li X; Chen J; Du Q; Zhang F; Zhang X Cancer Biomark; 2017 Dec; 21(1):55-63. PubMed ID: 29081406 [TBL] [Abstract][Full Text] [Related]
45. Long noncoding RNA XIST acts as an oncogene in non-small cell lung cancer by epigenetically repressing KLF2 expression. Fang J; Sun CC; Gong C Biochem Biophys Res Commun; 2016 Sep; 478(2):811-7. PubMed ID: 27501756 [TBL] [Abstract][Full Text] [Related]
46. Correlations of lysyl oxidase with MMP2/MMP9 expression and its prognostic value in non-small cell lung cancer. Liu J; Ping W; Zu Y; Sun W Int J Clin Exp Pathol; 2014; 7(9):6040-7. PubMed ID: 25337249 [TBL] [Abstract][Full Text] [Related]
47. Increased long noncoding RNA LINP1 expression and its prognostic significance in human breast cancer. Liu XM; Yang B; Han J Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8749-8754. PubMed ID: 30575915 [TBL] [Abstract][Full Text] [Related]
48. Serum microRNA-365 in combination with its target gene TTF-1 as a non-invasive prognostic marker for non-small cell lung cancer. Liu Y; Zhang G; Li H; Han L; Fu A; Zhang N; Zheng Y Biomed Pharmacother; 2015 Oct; 75():185-90. PubMed ID: 26337230 [TBL] [Abstract][Full Text] [Related]
49. Long non-coding RNA LUCAT1 is associated with poor prognosis in human non-small lung cancer and regulates cell proliferation via epigenetically repressing p21 and p57 expression. Sun Y; Jin SD; Zhu Q; Han L; Feng J; Lu XY; Wang W; Wang F; Guo RH Oncotarget; 2017 Apr; 8(17):28297-28311. PubMed ID: 28423699 [TBL] [Abstract][Full Text] [Related]
50. Expression and correlation of MALAT1 and SOX9 in non-small cell lung cancer. Chen W; Zhao W; Chen S; Zhang L; Guo Z; Wang L; Wang J; Wan Z; Hong Y; Yu L Clin Respir J; 2018 Jul; 12(7):2284-2291. PubMed ID: 29896925 [TBL] [Abstract][Full Text] [Related]
51. Bioinformatics analysis of LINC00426 expression in lung cancer and its correlation with patients' prognosis. Du W; Sun J; Gu J; Zhang S; Zhang T Thorac Cancer; 2020 Jan; 11(1):150-155. PubMed ID: 31691516 [TBL] [Abstract][Full Text] [Related]
52. Upregulation of tissue long noncoding RNA X inactive specific transcript predicts poor postoperative survival in patients with non-small cell lung cancer. Fang H; Yang L; Fan Y; Mo C; Luo L; Liang D; Jiang Y Medicine (Baltimore); 2020 Dec; 99(50):e21789. PubMed ID: 33327221 [TBL] [Abstract][Full Text] [Related]
53. Expression and clinical evidence of miR-494 and PTEN in non-small cell lung cancer. Wang J; Chen H; Liao Y; Chen N; Liu T; Zhang H; Zhang H Tumour Biol; 2015 Sep; 36(9):6965-72. PubMed ID: 25861022 [TBL] [Abstract][Full Text] [Related]
54. Study on expression of lncRNA RGMB-AS1 and repulsive guidance molecule b in non-small cell lung cancer. Li P; Li J; Yang R; Zhang F; Wang H; Chu H; Lu Y; Dun S; Wang Y; Zang W; Du Y; Chen X; Zhao G; Zhang G Diagn Pathol; 2015 Jun; 10():63. PubMed ID: 26055877 [TBL] [Abstract][Full Text] [Related]
55. Long non-coding RNA MVIH is associated with poor prognosis and malignant biological behavior in breast cancer. Lei B; Xu SP; Liang XS; Li YW; Zhang JF; Zhang GQ; Pang D Tumour Biol; 2016 Apr; 37(4):5257-64. PubMed ID: 26555546 [TBL] [Abstract][Full Text] [Related]
56. Increased stathmin correlates with advanced stage and poor survival of non-small cell lung cancer. Rong B; Nan Y; Liu H; Gao W Cancer Biomark; 2017; 19(1):35-43. PubMed ID: 28282798 [TBL] [Abstract][Full Text] [Related]
57. Matrix-remodeling associated 5 as a novel tissue biomarker predicts poor prognosis in non-small cell lung cancers. He Y; Chen X; Liu H; Xiao H; Kwapong WR; Mei J Cancer Biomark; 2015; 15(5):645-51. PubMed ID: 26406953 [TBL] [Abstract][Full Text] [Related]
58. High expression of long non-coding RNA SBF2-AS1 promotes proliferation in non-small cell lung cancer. Lv J; Qiu M; Xia W; Liu C; Xu Y; Wang J; Leng X; Huang S; Zhu R; Zhao M; Ji F; Xu L; Xu K; Yin R J Exp Clin Cancer Res; 2016 May; 35():75. PubMed ID: 27154193 [TBL] [Abstract][Full Text] [Related]
59. Analysis of Long Non-Coding RNA Expression Profiles in Non-Small Cell Lung Cancer. Wang L; Chen Z; An L; Wang Y; Zhang Z; Guo Y; Liu C Cell Physiol Biochem; 2016; 38(6):2389-400. PubMed ID: 27299310 [TBL] [Abstract][Full Text] [Related]
60. Overexpressed LAPTM4B-35 is a risk factor for cancer recurrence and poor prognosis in non-small-cell lung cancer. Kong F; Gao F; Chen J; Sun Y; Zhang Y; Liu H; Li X; Yang P; Zheng R; Liu G; Jia Y Oncotarget; 2016 Aug; 7(35):56193-56199. PubMed ID: 27486880 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]